Blog
4 June 2026
New Melanoma Vaccine Cuts Recurrence Risk by Nearly Half After 5 Years
New melanoma vaccine combined with immunotherapy cuts skin cancer recurrence risk by nearly half after 5 years, offering hope for...
Read more
How Gene Expression Profiling Guides Sentinel Node Biopsies in Early Melanoma
Discover how gene expression profiling enhances sentinel node biopsy decisions in early melanoma, improving personalized treatment and patient outcomes.
4 06 2026
Read more
How Auditory Distraction Eases Pain During Cosmetic Botulinum Injections
Discover how auditory distraction like music and white noise can ease pain during cosmetic botulinum injections, improving comfort for first-time...
5 06 2026
Read more
Top Dermatology News: Pain Relief, HS Studies, and Immunotherapy Updates
Stay updated on dermatology breakthroughs: pain relief tips, hidradenitis suppurativa studies, psoriasis dosing, and new immunotherapy insights.
2 06 2026
Read more
Pure PDGF-BB Safety Sets New Standard in Regenerative Aesthetic Care
Discover how pure PDGF-BB’s 30-year safety record is setting a new standard in regenerative aesthetic care and transforming skin treatments.
3 06 2026
Read more
Topical QTORIN Rapamycin Cuts Bleeding in Cutaneous Venous Malformations
Topical QTORIN rapamycin shows promise in reducing bleeding and improving symptoms in cutaneous venous malformations, offering hope for new treatment...
31 05 2026
Read more
How Dr. Kavita Mariwalla Addresses Rising Skin Cancer Risks in Youth
Dr. Kavita Mariwalla reveals why skin cancer rates are rising in youth and how dermatologists tackle prevention, education, and early...
1 06 2026
Read more
Early Hidradenitis Suppurativa Diagnosis Cuts Costs and Improves Care Outcomes
Early diagnosis of hidradenitis suppurativa improves treatment outcomes, cuts healthcare costs, and highlights ongoing racial and socioeconomic disparities.
30 05 2026
Read more
Corabotase Demonstrates Sustained Efficacy and High Patient Satisfaction in Phase 2 Glabellar Lines Study
Ipsen recently announced new phase 2 data showing that its investigational recombinant neuroinhibitor corabotase may have a prolonged effect in...
29 05 2026
Read more